Grant: Applied Research and Development Grants - Level 1
Fanshawe College of Applied Arts & Technology
$24,285.00
Assessment and Application of a High Performance Liquid Chromatography Methodology for BLES Biochemicals Inc.
EF 2016-17
Résumé
BLES Biochemicals Inc. is a small London-based Canadian pharmaceutical company that manufactures and distributes the pulmonary surfactant BLES?. BLES? (bovine lipid extract surfactant) is an exogenous lung surfactant indicated for rescue treatment of Neonatal Respiratory Distress Syndrome (NRDS). It was developed in the 1970s at Western University and is now used in over 110 hospitals across Canada and approved for international use in several countries including India, South Africa, Iran, and Saudi Arabia, with registration in several others pending. International demand for their product will increase over 50% in the next two years this coupled with the fact that BLES currently uses thin layer chromatography (TLC) a extremely time consuming method phospholipid assessment has brought BLES to Fanshawe College and the School of Applied Science & Technology (AST), specifically the Bachelors of Applied Technology Biotechnology program to examine high performance liquid chromatography (HPLC) as a method for assessing phospholipid composition. The HPLC method can be completed in hours instead of days. To assess feasibility and develop a robust HPLC method, Principal Investigators Dr. Michael Jennings, and Dr. Cheryl Ketola, in conjunction with student researcher, will complete, design and execute experiments on the impact of column size and solvent mixture, and test the accuracy, repeatability and robustness of the HPLC method in formulation under constant conditions. Results of this project are critical to BLES' operations; without development of this methodology they will not be able to meet increasing international demand. Dependent on outcomes of the project, BLES will consider purchasing their own HPLC equipment. This purchase would coincide with creation of a new technician position, to operate and maintain the equipment. Through participation in this project, the Fanshawe student will improve his/her understanding of TLC and HPLC methodologies, experimental design and testing, lab procedures, and will participate in a research project in a client facing role.
Programme
Applied Research and Development Grants - Level 1
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
493581-2015
Name nom
Douglas, Daniel
Department département
Head Office
Organization id
23818
Institution établissement
Fanshawe College of Applied Arts & Technology
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2015
Award amount
24285
Program id
CARD1
Program name en
Applied Research and Development Grants - Level 1
Program name fr
Subventions de recherche et développement appliquée - niveau 1
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1561
Committee name en
Applied Research and Development Grants
Committee name fr
Subventions de recherche et développement appliquée
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
5400
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Biochemistry
Research subject fr
Biochimie
Partie
1
Nb partie
1
Application title
Assessment and Application of a High Performance Liquid Chromatography Methodology for BLES Biochemicals Inc.
Keyword
NSERC
Application summary
BLES Biochemicals Inc. is a small London-based Canadian pharmaceutical company that manufactures and distributes the pulmonary surfactant BLES?. BLES? (bovine lipid extract surfactant) is an exogenous lung surfactant indicated for rescue treatment of Neonatal Respiratory Distress Syndrome (NRDS). It was developed in the 1970s at Western University and is now used in over 110 hospitals across Canada and approved for international use in several countries including India, South Africa, Iran, and Saudi Arabia, with registration in several others pending. International demand for their product will increase over 50% in the next two years this coupled with the fact that BLES currently uses thin layer chromatography (TLC) a extremely time consuming method phospholipid assessment has brought BLES to Fanshawe College and the School of Applied Science & Technology (AST), specifically the Bachelors of Applied Technology Biotechnology program to examine high performance liquid chromatography (HPLC) as a method for assessing phospholipid composition. The HPLC method can be completed in hours instead of days. To assess feasibility and develop a robust HPLC method, Principal Investigators Dr. Michael Jennings, and Dr. Cheryl Ketola, in conjunction with student researcher, will complete, design and execute experiments on the impact of column size and solvent mixture, and test the accuracy, repeatability and robustness of the HPLC method in formulation under constant conditions. Results of this project are critical to BLES' operations; without development of this methodology they will not be able to meet increasing international demand. Dependent on outcomes of the project, BLES will consider purchasing their own HPLC equipment. This purchase would coincide with creation of a new technician position, to operate and maintain the equipment. Through participation in this project, the Fanshawe student will improve his/her understanding of TLC and HPLC methodologies, experimental design and testing, lab procedures, and will participate in a research project in a client facing role.